Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze RGEN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate RGEN investment potential.

What is RGEN stock price today?

Get real-time RGEN stock price, historical data, and price charts on Financhill. Track RGEN performance with our advanced analysis tools.

Is RGEN a good investment?

Evaluate RGEN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy RGEN stock?

To buy RGEN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of RGEN?

View detailed market capitalization data and company valuation metrics for RGEN on our comprehensive analysis page.

What is the P/E ratio of RGEN?

Use our fundamental analysis tools to view RGEN P/E ratio and compare valuation metrics with industry peers.

What are RGEN earnings?

View RGEN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Repligen Corp. 10K Form

Sell

RGEN
Repligen Corp.

Last Price:

$114.14

Seasonality Move:

6.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01	10Q	RGEN/Repligen Corp. Quarterly
2023-10-31	10Q	RGEN/Repligen Corp. Quarterly
2023-08-02	10Q	RGEN/Repligen Corp. Quarterly
2023-05-02	10Q	RGEN/Repligen Corp. Quarterly
2022-11-01	10Q	RGEN/Repligen Corp. Quarterly
2022-08-02	10Q	RGEN/Repligen Corp. Quarterly

Receive RGEN News And Ratings

See the #1 stock for the next 7 days that we like better than RGEN

RGEN Financial Statistics

Sales & Book Value

Annual Sales:	$738.3M
Cash Flow:	$17.4M
Price / Cash Flow:	70.45
Annual Sales:	$37.39
Price / Book:	3.05

Profitability

EPS (TTM):	0.86450
Net Income (TTM):	$48.9M
Gross Margin:	$350.6M
Return on Equity:	2.4%
Return on Assets:	1.69%

Repligen Corp. Earnings Forecast

Key Repligen Corp. Financial Ratios

The Gross Profit Margin over the past 41 years for RGEN is 47.50%.
The Selling, General & Administrative Expenses for RGEN have been equal to 39.35% of Gross Profit Margin.
The Research & Development expenses have been 6.95% of Revenue.
The Interest Expense is 47.39% of Operating Income.
The Net Earning history of RGEN is 6.62% of Total Revenues.
Per Share Earnings over the last 41 years have been positive in 19 years.

Repligen Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Life Sciences Tools & Services
Sector:	Health Care
Current Symbol:	RGEN
CUSIP:	759916
Website:	repligen.com

Debt

Debt-to-Equity Ratio:	0.33
Current Ratio:	8.37
Quick Ratio:	6.84

Price-to-Earnings

Trailing P/E Ratio:	132.11
Forward P/E Ratio:	45.54

RGEN Technical Analysis vs Fundamental Analysis